BESTAGRO

Current scenario - Revenue declined due to challenging Kharif season, uneven monsoon, and strategic reduction of low-margin generic product portfolio in favor of patented products. - Profitability improved significantly despite lower revenue, driven by higher gross margins and cost discipline. - Operating expenses (excluding finance costs and depreciation) reduced by 12% in Q2 and 5% in H1. Management Guidance & Outlook - Management expects H2 performance to be better than last year with no anticipated losses, considering 2025-26 as the bottom-out year. - Higher provisions have been created for sales returns to absorb any shocks and prevent unexpected surprises in future quarters. - Annual revenue growth of 10-15% may be challenging to achieve due to a conscious shift away from generics, but profitability and margins are expected to remain strong. Growth Drivers & Expansion - Continued strong focus on expanding the patented product portfolio and supplying to large MNCs and domestic players like SWAL Corporation and Adama. - International business is expanding, highlighted by a step-down subsidiary incorporated in Brazil, product registrations in Nepal and Mexico, and shipments to Sudan. - Received 13 CIB registrations during the quarter.

- Best Agrolife Limited has uploaded the audio recording of the earnings conference call for the quarter and half year ended September 30, 2026. - The call was held on Monday, November 02, 2026. - The recording is made available on the company website under the investor section.

- Q2 FY27 was challenging for the domestic crop protection industry due to irregular monsoon rainfall and delayed sowing. - Despite headwinds, EBITDA grew 30% in Q2 FY27 and 45% in H1 FY27, driven by a strategic shift towards patented products and cost discipline. - Secured a patent grant for the combination of Fluxametamide, Abamectin, and Trifloxystrobin, and obtained 13 new CIB registrations. - Advanced international business with a 47 MT shipment to Sudan, and product registrations/approvals in Nepal, Mexico, Taiwan, and Sri Lanka.

- Appointment of Mr. Sanjeev Bajaj as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) with immediate effect from October 30, 2026. - Mr. Vikas Jain transitioned from CFO to Vice President - Business Operations, ceasing to be KMP. - Approved grant of Employee Stock Options under the Best Agrolife ESOP Scheme 2024, subject to stock exchange approvals.

- Mr. Sanjeev Bajaj appointed as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) with immediate effect. - Mr. Vikas Jain re-designated from CFO to Vice President - Business Operations, ceasing to be CFO and KMP. - Approved un-audited financial results for the quarter and half-year ended September 30, 2026, and the grant of ESOPs under Employee Stock Option Scheme 2024.

Q2 FY27 Consolidated Revenue ₹407Cr (▼21% YoY) EBITDA ₹101Cr (▲30% YoY) PAT ₹57Cr (▲48% YoY) EBITDA Margin 25% vs 15% (▲1000bps)